Consumer telehealth and wellness brand Hims & Hers wrapped up its merger with special purpose acquisition company (SPAC) Oaktree Acquisition Tuesday, and today began trading on the New York Stock Exchange.
The deal was first announced in October, and was originally expected to close before the end of its Q4 2020. After Tuesday's approval, the deal has provided Hims with $279.5 million, $205...
As Hims & Hers prepares for the public market, it’s adding new members to its board with backgrounds in investing and consumer tech. This morning it exclusively announced to MobiHealthNews two new board members Lynne Chou O’Keefeand David Wells.
O’Keefe comes from an investment background. She is the founder and managing partner of Define Ventures and served as a partner in the Life Sciences...
Digital pharmacy Hims & Hers has reported 91% year-over-year growth during the third quarter of this year.
This comes just weeks after the company announced a merger agreement with Oaktree Capital Management-sponsored special purpose acquisition company (SPAC) Oaktree Acquisition. The public can expect the reverse merger to close at the end of the fourth quarter of 2020.
Hims made a name...
Consumer-friendly telehealth and mail-order wellness product service Hims is officially entering the public markets. Today it announced a merger agreement with Oaktree Capital Management-sponsored special purpose acquisition company (SPAC) Oaktree Acquisition Corp.
The reverse merger is expected to close in the fourth quarter of 2020, and places the combined entity at a roughly $1.6 billion...
About the authors: Andrew Dudum is the CEO and founder of Hims & Hers, a consumer-facing digital health company offering telehealth services.
Joel White is executive director of the Health Innovation Alliance, a coalition of health and technology leaders who support policies that use technology and data to make healthcare work better.
Outside of these positions, Dudum and White report no...
Austin, Texas-based virtual and on-demand care provider Remedy announced Dr. Ronald Dixon as its chief medical officer. Dixon, formerly the head of clinical affairs at Onduo and the president and CEO of Onduo Professionals (its provider staffing group), is expected to draw on his experience to help Remedy build out its virtual chronic care treatment services.
“Dr. Dixon’s experience in developing...
D2C wellness and telehealth startup Hims & Hers is looking to cut down the time between medication orders and delivery for certain customers.
Thanks to a newly announced partnership, patients receiving virtual primary care services through Hims & Hers may choose to select Alto as their preferred pharmacy for prescription deliveries. They will have their orders fulfilled automatically ...
